{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:10:07Z","timestamp":1791519007947,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Daewoong Pharmaceutical Co."}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.diabres.2018.06.002","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T11:49:04Z","timestamp":1528717744000},"page":"335-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"special_numbering":"C","title":["Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"142","author":[{"given":"Kwang Hwan","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hwan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Pio","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2875-9276","authenticated-orcid":false,"given":"Seung-Kyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo-Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9601-396X","authenticated-orcid":false,"given":"Bom Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2018.06.002_b0005","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.06.002_b0010","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00125-004-1463-y","article-title":"The diabetic foot: from art to science. The 18th Camillo Golgi lecture","volume":"47","author":"Boulton","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2018.06.002_b0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12882-017-0711-6","article-title":"Factors associated with foot ulceration and amputation in adults on dialysis: a cross-sectional observational study","volume":"18","author":"Kaminski","year":"2017","journal-title":"BMC Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2018.06.002_b0020","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1002\/dmrr.476","article-title":"International working group on wound H, treatments for people with diabetic foot U. Wound healing and treatments for people with diabetic foot ulcers","volume":"20","author":"Jeffcoate","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabres.2018.06.002_b0025","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(05)67700-8","article-title":"Wound healing and its impairment in the diabetic foot","volume":"366","author":"Falanga","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2018.06.002_b0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ndt\/16.4.695","article-title":"Diabetic foot ulcers: old problems\u2013new technologies","volume":"16","author":"Mulder","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2018.06.002_b0035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1464-5491.2004.01375.x","article-title":"Healing diabetic neuropathic foot ulcers: are we getting better?","volume":"22","author":"Margolis","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2018.06.002_b0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40824-016-0056-4","article-title":"Development of stabilized growth factor-loaded hyaluronate-collagen dressing (HCD) matrix for impaired wound healing","volume":"20","author":"Choi","year":"2016","journal-title":"Biomater Res"},{"key":"10.1016\/j.diabres.2018.06.002_b0045","doi-asserted-by":"crossref","first-page":"e1873","DOI":"10.1097\/MD.0000000000001873","article-title":"Promoting diabetic wound therapy using biodegradable rhPDGF-loaded nanofibrous membranes: CONSORT-compliant article","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.diabres.2018.06.002_b0050","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/wrr.12205","article-title":"Clinical application of growth factors and cytokines in wound healing","volume":"22","author":"Barrientos","year":"2014","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.diabres.2018.06.002_b0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/bjs.4019","article-title":"Growth factors in the treatment of diabetic foot ulcers","volume":"90","author":"Bennett","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.diabres.2018.06.002_b0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1531003512442093","article-title":"Epidermal growth factor in the treatment of diabetic foot ulcers: an update","volume":"24","author":"Tiaka","year":"2012","journal-title":"Perspect Vasc Surg Endovasc Ther"},{"key":"10.1016\/j.diabres.2018.06.002_b0065","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0021-9258(19)83739-0","article-title":"Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal","volume":"237","author":"Cohen","year":"1962","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2018.06.002_b0070","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/1523-1747.ep12876204","article-title":"Epidermal and dermal effects of epidermal growth factor during wound repair","volume":"94","author":"Nanney","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.diabres.2018.06.002_b0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3892\/ijmm.2017.2911","article-title":"Kindlin-1 contributes to EGF-induced re-epithelialization in skin wound healing","volume":"39","author":"Shen","year":"2017","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.diabres.2018.06.002_b0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1742-481X.2009.00594.x","article-title":"The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: the preliminary results","volume":"6","author":"Tuyet","year":"2009","journal-title":"Int Wound J"},{"key":"10.1016\/j.diabres.2018.06.002_b0085","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.2337\/diacare.26.6.1856","article-title":"Human epidermal growth factor enhances healing of diabetic foot ulcers","volume":"26","author":"Tsang","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.06.002_b0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00006534-199108000-00001","article-title":"Stimulation of healing of chronic wounds by epidermal growth factor","volume":"88","author":"Brown","year":"1991","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.diabres.2018.06.002_b0095","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.sap.0000198731.12407.0c","article-title":"Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers","volume":"56","author":"Hong","year":"2006","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.diabres.2018.06.002_b0100","first-page":"207","article-title":"Stochastically curtailed tests in long term clinical trials","volume":"1","author":"Gordon Lan","year":"1982","journal-title":"Sequent Anal"},{"key":"10.1016\/j.diabres.2018.06.002_b0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cpm.2014.09.010","article-title":"Growth factors in wound healing: the present and the future?","volume":"32","author":"Dinh","year":"2015","journal-title":"Clin Podiatr Med Surg"},{"key":"10.1016\/j.diabres.2018.06.002_b0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4142\/jvs.2006.7.2.105","article-title":"Topical application of epidermal growth factor accelerates wound healing by myofibroblast proliferation and collagen synthesis in rat","volume":"7","author":"Kwon","year":"2006","journal-title":"J Vet Sci"},{"key":"10.1016\/j.diabres.2018.06.002_b0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/SAP.0b013e31815bfeac","article-title":"The effect of continuous release of recombinant human epidermal growth factor (rh-EGF) in chitosan film on full thickness excisional porcine wounds","volume":"61","author":"Hong","year":"2008","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.diabres.2018.06.002_b0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/bj2470385","article-title":"Epidermal growth factor increases collagen production in granulation tissue by stimulation of fibroblast proliferation and not by activation of procollagen genes","volume":"247","author":"Laato","year":"1987","journal-title":"Biochem J"},{"key":"10.1016\/j.diabres.2018.06.002_b0125","doi-asserted-by":"crossref","first-page":"834893","DOI":"10.1155\/2015\/834893","article-title":"Roles of proteoglycans and glycosaminoglycans in wound healing and fibrosis","volume":"2015","author":"Ghatak","year":"2015","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.diabres.2018.06.002_b0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0094-1298(20)32474-3","article-title":"Understanding dressings","volume":"25","author":"Ladin","year":"1998","journal-title":"Clin Plast Surg"},{"key":"10.1016\/j.diabres.2018.06.002_b0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/diacare.18.1.64","article-title":"Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study","volume":"18","author":"Richard","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.06.002_b0140","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2337\/diacare.21.5.822","article-title":"Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study","volume":"21","author":"Wieman","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.06.002_b0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1524-475x.2000.00162.x","article-title":"Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy","volume":"8","author":"Embil","year":"2000","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.diabres.2018.06.002_b0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1742-481X.2007.00344.x","article-title":"Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation","volume":"4","author":"Fernandez-Montequin","year":"2007","journal-title":"Int Wound J"},{"key":"10.1016\/j.diabres.2018.06.002_b0155","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1742-481X.2009.00641.x","article-title":"Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study","volume":"6","author":"Fernandez-Montequin","year":"2009","journal-title":"Int Wound J"},{"key":"10.1016\/j.diabres.2018.06.002_b0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jdiacomp.2008.02.001","article-title":"Fifty percent area reduction after 4 weeks of treatment is a reliable indicator for healing\u2013analysis of a single-center cohort of 704 diabetic patients","volume":"23","author":"Coerper","year":"2009","journal-title":"J Diabetes Complications"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2018.06.002_b0165","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc10-S011","article-title":"Standards of medical care in diabetes\u20132010","volume":"33","author":"American","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.06.002_b0170","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/jid.2011.176","article-title":"Hemoglobin A1c predicts healing rate in diabetic wounds","volume":"131","author":"Christman","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.diabres.2018.06.002_b0175","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7547\/15-176","article-title":"Does baseline hemoglobin A1c level predict diabetic foot ulcer outcome or wound healing time?","volume":"107","author":"Vella","year":"2017","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.diabres.2018.06.002_b0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/wound.2014.0571","article-title":"Quality randomized clinical trials of topical diabetic foot ulcer healing agents","volume":"5","author":"Bolton","year":"2016","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"10.1016\/j.diabres.2018.06.002_b0185","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","article-title":"The global burden of diabetic foot disease","volume":"366","author":"Boulton","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2018.06.002_b0190","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/diacare.24.2.290","article-title":"Apligraf Diabetic Foot Ulcer S. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial","volume":"24","author":"Veves","year":"2001","journal-title":"Diabetes Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822718306673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822718306673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T07:44:13Z","timestamp":1720338253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822718306673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":38,"alternative-id":["S0168822718306673"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2018.06.002","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2018.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}